Jan Lewerenz

8.3k total citations · 2 hit papers
79 papers, 4.5k citations indexed

About

Jan Lewerenz is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jan Lewerenz has authored 79 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Neurology, 30 papers in Molecular Biology and 25 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jan Lewerenz's work include Autoimmune Neurological Disorders and Treatments (16 papers), Neuroscience and Neuropharmacology Research (15 papers) and Peripheral Neuropathies and Disorders (10 papers). Jan Lewerenz is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (16 papers), Neuroscience and Neuropharmacology Research (15 papers) and Peripheral Neuropathies and Disorders (10 papers). Jan Lewerenz collaborates with scholars based in Germany, United States and Belgium. Jan Lewerenz's co-authors include Pamela Maher, Axel Methner, Philipp Albrecht, Ann Massie, Sandra J. Hewett, Ilse Smolders, Peter W. Gout, Maria P. Lambros, Vadivel Ganapathy and Ying Huang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jan Lewerenz

77 papers receiving 4.4k citations

Hit Papers

The Cystine/Glutamate Ant... 2012 2026 2016 2021 2012 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Cystine/Glutamate Antiporter System x c − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
    2012 767 citations Jan Lewerenz, Ann Massie et al. Antioxidants and Redox Signaling profile →
  2. Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?
    2015 563 citations Jan Lewerenz, Pamela Maher profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Lewerenz Germany 29 1.9k 974 950 580 566 79 4.5k
Axel Methner Germany 37 2.4k 1.2× 411 0.4× 914 1.0× 446 0.8× 623 1.1× 87 4.4k
Plamena R. Angelova United Kingdom 32 2.5k 1.3× 946 1.0× 817 0.9× 1.1k 1.9× 331 0.6× 78 4.8k
Amalia M. Dolga Netherlands 36 2.1k 1.1× 369 0.4× 825 0.9× 629 1.1× 525 0.9× 121 3.8k
Benjamin Drukarch Netherlands 43 1.9k 1.0× 1.4k 1.5× 1.6k 1.7× 809 1.4× 546 1.0× 143 5.4k
R. Anne Stetler United States 42 3.4k 1.8× 1.2k 1.2× 1.0k 1.1× 749 1.3× 277 0.5× 71 6.9k
Álvaro G. Estévez United States 39 2.0k 1.0× 1.4k 1.5× 920 1.0× 1.7k 2.9× 180 0.3× 94 5.2k
Ikuko Miyazaki Japan 39 1.4k 0.8× 1.2k 1.2× 1.6k 1.6× 548 0.9× 270 0.5× 131 4.7k
Sandra J. Hewett United States 31 1.6k 0.8× 320 0.3× 1.2k 1.2× 945 1.6× 330 0.6× 72 4.2k
Jan Albrecht Poland 41 2.2k 1.2× 349 0.4× 1.8k 1.8× 1.1k 1.9× 179 0.3× 187 6.3k
Sandra Moreno Italy 35 1.9k 1.0× 398 0.4× 845 0.9× 1.0k 1.7× 185 0.3× 80 3.6k

Countries citing papers authored by Jan Lewerenz

Since Specialization
Citations

This map shows the geographic impact of Jan Lewerenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lewerenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lewerenz more than expected).

Fields of papers citing papers by Jan Lewerenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Lewerenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lewerenz. The network helps show where Jan Lewerenz may publish in the future.

Co-authorship network of co-authors of Jan Lewerenz

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Lewerenz. A scholar is included among the top collaborators of Jan Lewerenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Lewerenz. Jan Lewerenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roll, Wolfgang, Jan Bauer, Andre Dik, et al.. (2024). [18F]DPA-714-PET-MRI reveals pronounced innate immunity in human anti-LGI1 and anti-CASPR2 limbic encephalitis. Journal of Neurology. 271(6). 3653–3659. 2 indexed citations
2.
Jesse, Sarah, Jan Lewerenz, Jan Kassubek, et al.. (2024). Blood–CSF barrier integrity in amyotrophic lateral sclerosis. Brain. 147(12). 4254–4264. 4 indexed citations
3.
Bischof, Gérard N., Norbert Brüggemann, Justina Dargvainiene, et al.. (2023). In Vivo Measurement of Tau Depositions in Anti-IgLON5 Disease Using [18F]PI-2620 PET. Neurology. 101(22). e2325–e2330. 7 indexed citations
4.
5.
Kehrer‐Sawatzki, Hildegard, et al.. (2022). The NF1 microdeletion syndrome: early genetic diagnosis facilitates the management of a clinically defined disease. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 20(3). 273–277. 5 indexed citations
6.
Schwenkenbecher, Philipp, Thomas Skripuletz, Peter Lange, et al.. (2021). Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis. Neurology Neuroimmunology & Neuroinflammation. 8(6). 20 indexed citations
7.
8.
Huss, André, Franziska Bachhuber, Jan Lewerenz, et al.. (2019). Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis. Clinica Chimica Acta. 498. 148–153. 9 indexed citations
9.
Lewerenz, Jan, et al.. (2019). Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis—A Systematic Analysis. Frontiers in Neurology. 10. 804–804. 120 indexed citations
10.
Bullinger, Lars, Jan Kassubek, Jens Dreyhaupt, et al.. (2017). Identifying ischemic stroke associated with cancer: a multiple model derived from a case–control analysis. Journal of Neurology. 264(4). 781–791. 19 indexed citations
11.
Thomas, Michael, et al.. (2017). SOP – Akuter Verwirrtheitszustand. Der Onkologe. 23(3). 213–217. 5 indexed citations
12.
Otto, Markus, et al.. (2016). Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β. BMC Neurology. 16(1). 185–185. 70 indexed citations
13.
Urbach, Horst, Sebastian Rauer, Irina Mader, et al.. (2015). Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis. Neuroradiology. 57(12). 1203–1209. 11 indexed citations
14.
Lewerenz, Jan, Paul Baxter, Philipp Albrecht, et al.. (2013). Phosphoinositide 3-Kinases Upregulate System x c − via Eukaryotic Initiation Factor 2α and Activating Transcription Factor 4 – A Pathway Active in Glioblastomas and Epilepsy. Antioxidants and Redox Signaling. 20(18). 2907–2922. 60 indexed citations
15.
Choe, Chi‐un, Jan Lewerenz, Christian Gerloff, Tim Magnus, & Sonia Donzelli. (2011). Nitroxyl in the Central Nervous System. Antioxidants and Redox Signaling. 14(9). 1699–1711. 20 indexed citations
16.
Lewerenz, Jan, Hideyo Sato, Philipp Albrecht, et al.. (2011). Mutation of ATF4 mediates resistance of neuronal cell lines against oxidative stress by inducing xCT expression. Cell Death and Differentiation. 19(5). 847–858. 55 indexed citations
17.
Lewerenz, Jan & Pamela Maher. (2010). Control of Redox State and Redox Signaling by Neural Antioxidant Systems. Antioxidants and Redox Signaling. 14(8). 1449–1465. 51 indexed citations
18.
Lewerenz, Jan, Richard Dargusch, & Pamela Maher. (2010). Lactacidosis modulates glutathione metabolism and oxidative glutamate toxicity. Journal of Neurochemistry. 113(2). 502–514. 35 indexed citations
19.
Lewerenz, Jan, Philipp Albrecht, Nadine Henke, et al.. (2009). Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxonein vitro. Journal of Neurochemistry. 111(2). 332–343. 153 indexed citations
20.
Maher, Pamela, Jan Lewerenz, Carles Barriocanal Lozano, & Josep Lluı́s Torres. (2008). A novel approach to enhancing cellular glutathione levels. Journal of Neurochemistry. 107(3). 690–700. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Axel Methner Breakdown of academic impact, for papers by Plamena R. Angelova Breakdown of academic impact, for papers by Amalia M. Dolga Breakdown of academic impact, for papers by Benjamin Drukarch Breakdown of academic impact, for papers by R. Anne Stetler Breakdown of academic impact, for papers by Álvaro G. Estévez Breakdown of academic impact, for papers by Ikuko Miyazaki Breakdown of academic impact, for papers by Sandra J. Hewett Breakdown of academic impact, for papers by Jan Albrecht Breakdown of academic impact, for papers by Sandra Moreno
Rankless by CCL
2026